These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8698279)

  • 1. Tea drinking and haemostasis: a randomized, placebo-controlled, crossover study in free-living subjects.
    Vorster H; Jerling J; Oosthuizen W; Cummings J; Bingham S; Magee L; Mulligan A; Runswick S
    Haemostasis; 1996; 26(1):58-64. PubMed ID: 8698279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
    Smith AM; English KM; Malkin CJ; Jones RD; Jones TH; Channer KS
    Eur J Endocrinol; 2005 Feb; 152(2):285-91. PubMed ID: 15745938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit.
    Bingham SA; Vorster H; Jerling JC; Magee E; Mulligan A; Runswick SA; Cummings JH
    Br J Nutr; 1997 Jul; 78(1):41-55. PubMed ID: 9292758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals.
    de Maat MP; Pijl H; Kluft C; Princen HM
    Eur J Clin Nutr; 2000 Oct; 54(10):757-63. PubMed ID: 11083483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic variability of hemostatic and fibrinolytic factors in young women.
    Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans.
    Hodgson JM; Puddey IB; Mori TA; Burke V; Baker RI; Beilin LJ
    Eur J Clin Nutr; 2001 Oct; 55(10):881-6. PubMed ID: 11593350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Thromb Haemost; 1999 Mar; 81(3):367-72. PubMed ID: 10102462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
    Opatrný K; Opatrná S; Vít L; Opatrný K
    Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
    Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
    Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability.
    Stegnar M; Cuderman TV; Bozic M
    Clin Chem Lab Med; 2007; 45(1):40-6. PubMed ID: 17243913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat hypertension and haemostatic/fibrinolytic balance disorders.
    Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
    Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.
    Tofler GH; D'Agostino RB; Jacques PF; Bostom AG; Wilson PW; Lipinska I; Mittleman MA; Selhub J
    Thromb Haemost; 2002 Nov; 88(5):799-804. PubMed ID: 12428097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.
    Primrose JN; Davies JA; Prentice CR; Hughes R; Johnston D
    Thromb Haemost; 1992 Oct; 68(4):396-9. PubMed ID: 1448769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight change and blood coagulability and fibrinolysis in healthy obese women.
    Rissanen P; Vahtera E; Krusius T; Uusitupa M; Rissanen A
    Int J Obes Relat Metab Disord; 2001 Feb; 25(2):212-8. PubMed ID: 11410822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.